VX-166

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVX-166
Drug Alias NameVX-166
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase inhibitors
TargetsCaspase
Therapy Area/IndicationsLiver FailureSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVertex Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsLiver FailureSepsis

Other Information

ATC CodeN/A
Related LinksN/A